SI-BONE Inc. (SIBN) PT Raised to $24 at Needham

Needham analyst David Saxon raised the price target on SI-BONE Inc. (NASDAQ: SIBN) to $24.00 (from $20.00) while maintaining a Buy rating.

The analyst commented: "SIBN’s 4Q24 revenue was in line with its preannouncement and management provided 2025 revenue guidance above consensus. Procedure volume growth improved from the prior quarter and SIBN's active surgeon base reached another record. As expected, management guided to adjusted EBITDA profitability for 2025. We believe there could be upside to SIBN's revenue guidance which likely drops through to profitability. We reiterate our Buy rating and raise our price target to $24 (from $20)."

You May Also Be Interested In

• Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
• Weatherford International plc (WFRD) PT Lowered to $116 at UBS
• Hertz Energy cancels private placement announced in September